- Citations, last 5 years
- 508
- Works, last 5 years
- 48
- h-index
- 72
- Scientists listed
- 3
- Grants since 2016
- 8
Grants received
2025–2027 · training · Global Growth & Opportunity
Pratham International - To test and scale AI driven automation of Teaching at the Right Level (TaRL) approach in SSA
PRA Health Sciences · funded by Bill and Melinda Gates Foundation
2023–2024 · cooperative agreement · U44
Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.
Namasivayam Ambalavanan · PRA Health Sciences · funded by National Institutes of Health
2023–2024 · research · R44
Prapela™ SVS: A cost-effective stochastic vibrotactile stimulation device toimprove the clinical course of infants with neonatal abstinence syndrome.
John Phillip Konsin · PRA Health Sciences · funded by National Institutes of Health
2023–2026 · cooperative agreement · U44
Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.
Namasivayam Ambalavanan · PRA Health Sciences · funded by National Institutes of Health
2023–2027 · cooperative agreement · U44
Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.
Namasivayam Ambalavanan · PRA Health Sciences · funded by National Institutes of Health
2019–2023 · research · R44
Prapela™ SVS: A cost-effective stochastic vibrotactile stimulation device toimprove the clinical course of infants with neonatal abstinence syndrome.
John Phillip Konsin · PRA Health Sciences · funded by National Institutes of Health
2019–2020 · research · R43
Prapela™ SVS: A cost-effective stochastic vibrotactile stimulation device to improve the clinical course of infants with neonatal abstinence syndrome.
John Phillip Konsin · PRA Health Sciences · funded by National Institutes of Health
2019–2024 · research · R44
Prapela™ SVS: A cost-effective stochastic vibrotactile stimulation device toimprove the clinical course of infants with neonatal abstinence syndrome.
John Phillip Konsin · PRA Health Sciences · funded by National Institutes of Health